Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Placing

28 Jan 2016 07:00

RNS Number : 2322N
FastForward Innovations Limited
28 January 2016
 

For immediate release

28 January 2016

FastForward Innovations Limited

("FastForward" or the "Company")

Placing

Director Dealing

Further to the announcement by FastForward Innovations Limited (AIM: FFWD) on 11 January 2016, the Company is pleased to announce that it has today agreed to place 37,426,901new Ordinary Shares of 1p each (the "Placing Shares") at a price of 15p per Placing Share with a number of new and existing investors thereby raising US$8 million(£5,614,035 at an exchange rate of £1:US$1.425, being the rate on the date the Company determined the terms of the placing)before expenses (the "Placing"). The proceeds of the Placing will be used to assist the Company in making investments in accordance with its investing policy and for general working capital purposes.

In accordance with the terms of subscription letters signed by investors, payment for the Placing Shares is due by 5 February 2016. Subject to payment, application for the Placing Shares (which will rank paripassu with the existing Ordinary Shares) to be admitted to trading on AIM ("Admission") will be made with dealings expected to commence at 8.00 a.m. on 11 February2016.

 

The Company expects that the enlarged issued share capital following the issue of the Placing Shares will be 134,108,445Ordinary Shares (the "Enlarged Issued Share Capital").

Commenting on the Placing, Chief Executive Officer Mr.Lorne Abony noted:

"I am delighted to close the Placing today at a premium to our market price. The Placing was significantly over-subscribed. The fact that the Placing was over-subscribed is a very positive indicator for FFWD, given the global market conditions and the fact that we did not offer this placing to institutional investors. In addition,we are pleased to note a number of high profile placees, well known in the market as "smart money" investors, including Gigi Levy-Weiss, Norbert Teufelberger, Jim Mellon, Stephen Dattels and Russell Geyser; all of whom I believe will add considerably to FastForward as it grows its capital base and investment pipeline over the coming months."

Related Party Transaction

Mr Lorne Abony, Mr Stephen Dattels and Mr Jim Mellon(who are each Directors of the Company) have participated in the Placing. The participation of the Directors is as set out below:

Name

Subscription

Placing Shares

Total Ordinary Shares (inc. Placing Shares)

 

% interest in the Enlarged Issued Share Capital

Lorne Abony1

US$1,215,000

5,684,211

26,438,391

19.71%

Stephen Dattels2

US$500,000

2,339,181

15,209,248

11.34%

Jim Mellon3

US$250,000

1,169,591

10,425,991

7.77%

1 Lorne Abony's interest in shares is held by Abony Enterprises Limited Partnership, a limited partnership of which he is the majority legal owner.

2 Mr Dattels' interest in shares is held by Regent Mercantile Holdings Limited, a company owned by a trust under which Mr Dattels is a discretionary beneficiary. Mr Ian Burns is a director of Regent Mercantile Holdings Limited.

3 Mr Mellon's interest in shares is held by Galloway Limited, a company owned by a trust of which Mr James Mellon is a life tenant.

The Directors are related parties for the purposes of the AIM Rules. In addition, Mr Ian Burns is a director of Regent Mercantile Holdings Limited so is also regarded as a related party for the purposes of the Placing. The participation of the three Directorsin the Placing constitutes a Related Party Transaction under Rule 13 of the AIM Rules for Companies.

Accordingly, Mr Bryan Smith, the independent director of the Company for the purposes of the Placing, confirms that, having consulted with the Company's Nominated Adviser, the terms of the Placing are fair and reasonable insofar as the Company's shareholders are concerned. In particular Mr Smith notes that the Directors have participated on the same terms as all other placees and that the Placing is at a premium to the current market price.

The Investors

In addition to Mr Abony, Mr Mellon and Mr Dattels, following the issue of the Placing Shares the following shareholders will be interested in more than 3 per cent. ofthe Enlarged Issued Share Capital:

Name

Subscription

Placing Shares

Total Ordinary Shares (inc. Placing Shares)

 

% interest in the Enlarged Issued Share Capital

Russell Geyser

US$2,000,000

9,356,725

12,641,876

9.43%

Mr Norbert Teufelberger

US$1,000,000

4,678,363

8,784,802

6.55%

Gigi Levy-Weiss

US$1,050,000

4,678,363

4,678,363

3.49%

Issued Shares

Following Admission of the Placing Shares,the Company's enlarged issued share capital will consist of 134,108,445Ordinary Shares with voting rights. This number may be used by shareholders, following the Placing, as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

For further information please visit www.fstfwd.coor contact:

James Biddle/ Michael Cornish (Nomad)

Beaumont Cornish LimitedTel: +44 207 628 3396

 

Peterhouse Corporate Finance Limited

Guy Miller/ Lucy Williams

Tel: +44 (0) 207 469 0930

Elysium Fund Management Limited

PO Box 650

1st Floor

Royal Chambers

St Peter Port

Guernsey

GY1 3JX

 

Tel: +44 1481 810 100

Fax: +44 1481 810 120

e-mail: elysium@elysiumfundman.com

DISCLAIMER

Beaumont Cornish Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively as Nominated adviser to FastForward Innovations Limited and no one else in connection with the Placing and will not be responsible to anyone other than FastForward Innovations Limited for providing the protections afforded to clients of Beaumont Cornish Limited nor for providing advice in relation to the Placing. Neither Beaumont Cornish Limited nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Beaumont Cornish Limited in connection with this Announcement, any statement contained herein, or otherwise.

CAUTIONARY STATEMENT

The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of FastForwardInnovations Limited. There can be no assurance that such statements will prove to be accurate, achievable or recognisable in the near term.

Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. FastForwardInnovations Limited assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBCGDBUXDBGLR
Date   Source Headline
17th Nov 202010:30 amRNSHolding(s) in Company
12th Nov 20207:00 amRNSInvestee Company Update: Portage Biotech Inc.
5th Nov 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
16th Oct 20209:00 amRNSInvestee Company Update: EMMAC Life Sciences
13th Oct 20207:00 amRNSPlacing and Issue of Equity
23rd Sep 20201:30 pmRNSInvestee Company Update: Yooma Corp.
23rd Sep 20207:00 amRNSHolding(s) in Company
22nd Sep 20207:00 amRNSChange of Broker
17th Sep 20203:45 pmRNSResult of AGM
16th Sep 20204:00 pmRNSInvestee Company Update: Juvenescence Limited
8th Sep 20204:00 pmRNSUpdated Key Information Document
27th Aug 20204:30 pmRNSInvestee Company Update: Factom Inc.
26th Aug 20207:30 amRNSNotice of AGM
26th Aug 20207:00 amRNSFinal Results
25th Aug 20202:30 pmRNSInvestee Company Update: Portage Biotech Inc.
24th Aug 20203:15 pmRNSInvestee Company Update: Leap Gaming
18th Aug 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
5th Aug 20207:00 amRNSInvestee Company Update: Leap Gaming
30th Jul 20208:52 amRNSInvestee Company Update: Factom Inc.
30th Jul 20207:45 amRNSInvestee Company Update: Portage Biotech Inc.
28th Jul 202011:55 amRNSInvestee Company Update: EMMAC Life Sciences
22nd Jul 20201:39 pmRNSInvestee Company Update: EMMAC Life Sciences
14th Jul 202010:15 amRNSInvestee Company Update: Yooma Corp.
13th Jul 20205:01 pmRNSResult of Extraordinary General Meeting
9th Jul 20207:00 amRNSInvestee Company Update: Factom Inc.
6th Jul 202010:31 amRNSInvestee Company Update: Leap Gaming
26th Jun 202012:30 pmRNSNotice of EGM & Proposed Updated Investing Policy
22nd Jun 20207:45 amRNSInvestee Company Update: Leap Gaming
22nd Jun 20207:30 amRNSInvestee Company Update: Leap Gaming
22nd Jun 20207:00 amRNSInvestee Company Update: Factom Inc.
17th Jun 20201:00 pmRNSInvestee Company Update: Portage Biotech Inc.
2nd Jun 20209:30 amRNSInvestee Company Update: Juvenescence Limited
26th May 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
26th May 20207:00 amRNSInvestee Company Update: Portage Biotech Inc
21st May 20207:00 amRNSInvestee Company Update: Leap Gaming
19th May 20207:30 amRNSInvestee Company Update: EMMAC Life Sciences
18th May 20207:00 amRNSInvestee Company Update re Yooma and Board Changes
12th May 202010:15 amRNSInvestee Company Update: Portage Biotech Inc.
6th May 202012:30 pmRNSInvestee Company Update: Portage Biotech Inc.
23rd Apr 20203:15 pmRNSInvestee Company Update: Entertainment Direct Asia
23rd Apr 20207:00 amRNSHolding(s) in Company
16th Apr 20204:15 pmRNSInvestee Company Update: Portage Biotech Inc.
16th Apr 20202:00 pmRNSInvestee Company Update: Portage Biotech Inc.
14th Apr 20207:00 amRNSCorporate Update
2nd Apr 20207:00 amRNSInvestee Company Update: Factom Inc.
1st Apr 20207:00 amRNSInvestee Company Update: Leap Gaming
31st Mar 20201:15 pmRNSInvestee Company Update: EMMAC Life Sciences
20th Mar 20205:04 pmRNSInvestee Company Update: Entertainment Direct Asia
19th Mar 20202:30 pmRNSInvestee Company Update: Factom Inc.
17th Mar 20207:00 amRNSInvestee Company Update: Portage Biotech Inc.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.